January 10, 2012

ADVANCE Study of Bolton's Treovance EVAR Device Completes Enrollment

January 11, 2012—Bolton Medical, Inc. (Sunrise, FL) announced the completion of enrollment of its ADVANCE European clinical study, which is evaluating the safety and efficacy of the company's Treovance abdominal stent graft with Navitel delivery system for use in endovascular repair of abdominal aortic aneurysms. Thirty patients were enrolled in the study at five European hospitals.

According to the company, the Treovance device includes a flexible design, multiple fixation points, and a wide range of sizes. The low-profile Navitel delivery system is equipped with a detachable sheath and allows for controlled or rapid deployment of the Treovance device.

Principal Investigator Prof. Roberto Chiesa, MD, commented, “The Bolton ADVANCE study has been completed, and so far, the device shows promising results. I think that the Treovance abdominal stent graft continues a new generation of devices focused on providing low-profile systems, precise deployment, stent graft repositioning, and additionally, offers features to minimize late disconnections.”

Subscribe to our weekly newsletter.

Stay informed on the week's top stories including literature summaries, device approvals, guideline changes, and more. Plus, get our latest issues & supplements delivered to your inbox each month.

January 10, 2012

ADVANCE Study of Bolton's Treovance EVAR Device Completes Enrollment

Current Issue

Keep In Touch